美股新聞 標題聯播 · 近 24 小時 284 則 · 25 個來源 · 最新 9/20 06:32
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · KYNB近 30 天 1 則 · 第 1 / 1 頁
- Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
- Kyntra Bio Inc (KYNB) (Q2 2026) Earnings Call Highlights: Advancing FG-3246 and Roxadustat with ...
- Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates
- Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
- Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates
- Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates
- Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
- Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances ...
- Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates
- Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
- Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know
- RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。